$HBIO
Harvard Bioscience Inc
XNAS•Technology•Laboratory Analytical Instruments
$8.03
▲+0.75%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateHarvard Bioscience Inc
XNAS•Technology•Laboratory Analytical Instruments
Why is HBIO up today? It is at $8.03 (+0.75%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment HBIO spikes, and full due diligence on HBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $HBIO 1 time in the last 30 days. Create a free account to track $HBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on HBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystHARVARD BIOSCIENCE INC: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Benson Seth Benjamin Director | Acquired (grant/award) | +17K 0.4% of company | added 100% | 28K | n/a | Jun 9, 26 |
Gagnon Robert E. Director | Acquired (grant/award) | +17K 0.4% of company | added 100% | 28K | n/a | Jun 9, 26 |
Denelsky Stephen J Director | Acquired (grant/award) | +17K 0.4% of company | added 79% | 38K | n/a | Jun 9, 26 |
Snider William Director | Acquired (grant/award) | +17K 0.4% of company | added 52% | 49K | n/a | Jun 9, 26 |
Eade Katherine A. Director | Acquired (grant/award) | +17K 0.4% of company | added 39% | 59K | n/a | Jun 9, 26 |
Duke John D Officer | Acquired (grant/award) | +75K 1.6% of company | added 71% | 180K | n/a | Mar 20, 26 |
Frost Mark T Officer | Acquired (grant/award) | +30K 0.7% of company | added 100% | 48K | n/a | Mar 20, 26 |
Snider William Director | Bought (open market) | +8K 0.2% of company | added 36% | 32K | $41K at $4.85 | Mar 17, 26 |
Denelsky Stephen J Director | Bought (open market) | +10K 0.2% of company | added 91% | 21K | $49K at $4.87 | Mar 17, 26 |
Duke John D Officer | Bought (open market) | +5K 0.1% of company | added 5.0% | 105K | $25K at $5.01 | Mar 16, 26 |
Snider William Director | Bought (open market) | +13K 0.3% of company | added 100% | 24K | $62K at $4.99 | Mar 16, 26 |
Frost Mark T Officer | Bought (open market) | +5K 0.1% of company | added 40% | 18K | $25K at $5.00 | Mar 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in laboratory analytical instruments, closest in size first.
Here is the latest on HBIO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HBIO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
HBIO last traded at $8.03, up 0.75% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Harvard Bioscience Inc (HBIO) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The HBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged HBIO 1 time in the last 30 days.
HBIO (Harvard Bioscience Inc) trades on XNAS, with a market cap of about $36M in the Laboratory Analytical Instruments sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge HBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$HBIO discussion
Sign in to ask a question or join the discussion.